December News – KIFFIK Biomedical Inc.

KIFFIK Biomedical secures a pivotal $50 million investment from GEM Global Yield, positioning the company as a 'Unicorn-in-Waiting'

KIFFIK’s patented platform will disrupt current MedTech markets by offering real-time insights and personalized care in a way that was previously unimaginable while allowing healthcare professionals to fully diagnose, monitor, and more extensively treat patients remotely.

“I’m excited to announce a major milestone for KIFFIK Biomedical. We want to thank our new partners GEM, as we continue to deliver on our mission of bringing promising new diagnostic advancements to patients and researchers around the world.”

George Cagna

President & CEO

Play Video

KIFFIK Biomedical Featured on TV

Advancements – With Ted Danson

An educational series dedicated to the latest innovations, technologies, and sustainable breakthroughs impacting society.

Pioneering Animal Health Through Non-Invasive Technology

Here’s a glimpse into how KIFFIK’s technology is reshaping the animal health landscape:

Non-Invasive Biomarker Access: Unlike conventional methods, KIFFIK's technology enables seamless, continuous monitoring of biomarkers from interstitial fluid, eliminating the need for invasive blood or vein access.
Expanding Understanding of Diseases: By partnering with medical, veterinary researchers, and biopharmaceutical firms, KIFFIK is on a mission to broaden our understanding of diseases, which in turn, catalyzes the realm of preventive medicine and accelerates the discovery and development of new therapeutics.
Early Disease Detection: The ability to detect both systemic and localized biomarkers is a game-changer. This innovation facilitates early disease detection, allowing for timely interventions and better management of animal health.
Advancing Animal Research: KIFFIK’s technology is a valuable asset in animal research, aiding in the analysis of metabolic performance, nutrition, breeding, endurance, and high-performance training. It opens new doors in preventive healthcare and therapeutic discovery for animals.
Accelerated Therapeutic Discovery: With a deeper insight into disease mechanisms, KIFFIK's technology is poised to speed up the discovery and development of new therapeutics, both for human and animal healthcare.

For questions, please reach out to Mike Gallup: m.gallup@kiffik.com